Biochimica et biophysica acta. Molecular basis of disease
Cure8 research brief
Why This Matters
This preclinical study links periodontal ligament stem cells to reduced colitis severity in mice by restoring macrophage mitochondrial function and activating PINK1/Parkin-associated mitophagy, suggesting a possible new mechanistic target for future IBD therapies.
Who Should Pay Attention
Researchers in IBD, immunometabolism, mitophagy, stem-cell therapy; translational clinicians exploring novel regenerative approaches.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The paper describes in vitro co-culture experiments with PDLSCs and LPS-stimulated macrophages, plus therapeutic testing in DSS-induced colitis in mice.
PDLSC treatment was associated with reduced pro-inflammatory macrophage markers, increased anti-inflammatory markers, improved mitochondrial structure and function (membrane potential, respiratory complex activity, ATP), and increased PINK1/Parkin signaling.
The authors used RNA sequencing and mitochondrial gene sets to support mechanistic links and showed that blocking mitochondrial fission (Mdivi-1) altered the anti-inflammatory effects. The findings are preclinical: they come from cultured human cells and a mouse colitis model, not from human clinical trials.
This suggests a potential biological pathway (mitochondrial quality control/mitophagy) for future therapeutic research but does not demonstrate safety or efficacy in people.
Keep In Mind
Results are from in vitro experiments and a DSS mouse model (preclinical). The abstract supports mechanistic insights but does not constitute clinical evidence. Further research including safety and human trials is required.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationBiochimica et biophysica acta. Molecular basis of disease
AuthorsZekun Li, Yuhui Sun, Juefei Wu +7 more
InstitutionSchool of Stomatology, Shandong Second Medical University, Weifang, 261053, Shandong, China; Department of Orthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration & Shandong Provincial Clinical Research Center for Oral Diseases, Jinan, 250012, Shandong, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedAug 12, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Exosomes from IL-33-Stimulated Macrophages Regulate Epithelial Barrier Function to Ameliorate TNBS-Induced Colitis in Mice.
The study identifies a potential biologic approach (macrophage-derived exosomes) that improved epithelial repair and barrier function in a mouse colitis model, which could inform future therapeutic research for IBD.
E-cadherin acts as a dynamic switch in epithelial regeneration in inflammatory bowel disease.
If validated, transient modulation of epithelial E‑cadherin could become a new approach to promote mucosal healing — a key goal in IBD care. The findings point to epithelial repair biology rather than an approved patient...
Amelioration of Acute Oxazolone-Induced Colitis via Oral Administration of EPICERTIN, a Mucosal Healing Biotherapeutic for Inflammatory Bowel Disease
The study presents preclinical data that an orally delivered biotherapeutic (EPICERTIN) promotes epithelial repair and reduces inflammation in a UC-relevant mouse model — a potential step toward therapies that directly...